Tuesday, 7 May 2019

Alphabet's GV Leads Funding in Gene Editing Company Verve Therapeutics

GV led a $58.5 million investment to launch Verve Therapeutics, a new biotech focused on developing therapies that edit the human genome to treat heart diseases.

from RSS Feeds : RSS Feed - NDTV Gadgets360.com http://bit.ly/2DTO11A
Share:

0 comments:

Post a Comment

Blog Archive

Definition List

Unordered List

Support